| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,314,562 | 2,016,083 | 2,695,542 | 2,707,573 | | Cost of Revenue | 27,725 | 1,978,407 | 1,521,879 | 2,172,781 | | | Gross Profit | 2,286,837 | 37,676 | 1,173,663 | 534,792 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,623,467 | (444,040) | 594,151 | (23,918) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 198,222 | 202,348 | 208,715 | 205,867 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 465,148 | 279,368 | 370,797 | 352,843 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 17,641 | 21,739 | 20,579 | 50,552 | | Earnings Before Interest And Taxes | 482,789 | 301,107 | 391,376 | 401,050 | | Interest Expense | 129,749 | 129,452 | 131,575 | 152,252 | | Income Before Tax | 353,040 | 171,655 | 259,801 | 248,798 | | Income Tax Expense | 135,610 | 57,846 | 87,125 | 85,240 | | Minority Interest |
-
|
-
|
-
| (510) | | | | Net Income From Continuing Ops | 221,793 | 117,064 | 175,818 | 163,558 | | | Non-recurring Events | | Discontinued Operations | (965) | 43 | (1,751) | 518 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 220,828 | 117,107 | 174,067 | 164,076 | | Preferred Stock And Other Adjustments | (1,060) | (1,060) | (1,060) | (1,061) | | | Net Income Applicable To Common Shares | $219,768 | $116,047 | $173,007 | $163,015 |
|
1.52% Nasdaq 0.00%
Income Statement
